Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8020884rdf:typepubmed:Citationlld:pubmed
pubmed-article:8020884lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:8020884lifeskim:mentionsumls-concept:C2239176lld:lifeskim
pubmed-article:8020884lifeskim:mentionsumls-concept:C0007994lld:lifeskim
pubmed-article:8020884lifeskim:mentionsumls-concept:C0017837lld:lifeskim
pubmed-article:8020884lifeskim:mentionsumls-concept:C0449258lld:lifeskim
pubmed-article:8020884lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:8020884lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:8020884lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:8020884lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:8020884pubmed:issue1 Pt 1lld:pubmed
pubmed-article:8020884pubmed:dateCreated1994-7-29lld:pubmed
pubmed-article:8020884pubmed:abstractTextWe followed the expression of several glutathione S-transferase subunits in altered foci, liver neoplasms and metastases produced in male Fischer 344 rats by a modified Solt-Farber protocol, to determine whether components of the resistant phenotype are lost during neoplastic progression. At 6 mo after initiation, altered foci and persistent nodules displayed increased immunohistochemical expression of glutathione S-transferase subunits Yf (pi-class), Ya (alpha-class) and Yb1 (mu-class) in comparison with normal or surrounding liver tissue. However, although most altered foci exhibited little change in glutathione S-transferase Yb2 (mu-class) subunit expression, 5% of Yf-positive foci and nodules were partially or completely deficient in Yb2 expression. At 12 and 18 mo after initiation, most grossly visible hepatocellular tumors retained induced expression of glutathione S-transferase subunits Yf, Ya and Yb1, but 63% of the carcinomas, 88% of the primary metastatic carcinomas and 94% of the pulmonary metastases were deficient in Yb2 expression. These differences in glutathione S-transferase subunit expression were confirmed by quantitative analysis by reverse-phase HPLC of S-hexylglutathione affinity-purified glutathione S-transferases from advanced tumors. Cytosolic glutathione S-transferase activity for trans-4-phenyl-3-buten-2-one in advanced tumors ranged from 42% to 66% of the activity in matched surrounding liver, whereas glutathione S-transferase activities for 1-chloro-2,4-dinitrobenzene were increased by 140% to 161%. These studies demonstrate that progression of hepatocellular carcinomas in the resistant hepatocyte model of carcinogenesis in which several glutathione S-transferase subunits are induced is associated with the loss of a major constitutive mu-class hepatic glutathione S-transferase. Although the mechanism and role of the reduction or loss of glutathione S-transferase Yb2 during malignant progression are unknown, we propose that loss of glutathione S-transferase Yb2 in some preneoplastic populations of hepatocytes might be conducive to further DNA damage by presently unknown environmental or endogenous compounds that are normally detoxified preferentially by glutathione S-transferase isoenzymes containing this subunit.lld:pubmed
pubmed-article:8020884pubmed:languageenglld:pubmed
pubmed-article:8020884pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8020884pubmed:citationSubsetIMlld:pubmed
pubmed-article:8020884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8020884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8020884pubmed:statusMEDLINElld:pubmed
pubmed-article:8020884pubmed:monthJullld:pubmed
pubmed-article:8020884pubmed:issn0270-9139lld:pubmed
pubmed-article:8020884pubmed:authorpubmed-author:GordonS GSGlld:pubmed
pubmed-article:8020884pubmed:authorpubmed-author:HayesM AMAlld:pubmed
pubmed-article:8020884pubmed:authorpubmed-author:StalkerM JMJlld:pubmed
pubmed-article:8020884pubmed:authorpubmed-author:KocalT ETElld:pubmed
pubmed-article:8020884pubmed:authorpubmed-author:QuinnB ABAlld:pubmed
pubmed-article:8020884pubmed:issnTypePrintlld:pubmed
pubmed-article:8020884pubmed:volume20lld:pubmed
pubmed-article:8020884pubmed:ownerNLMlld:pubmed
pubmed-article:8020884pubmed:authorsCompleteYlld:pubmed
pubmed-article:8020884pubmed:pagination149-58lld:pubmed
pubmed-article:8020884pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8020884pubmed:meshHeadingpubmed-meshheading:8020884-...lld:pubmed
pubmed-article:8020884pubmed:meshHeadingpubmed-meshheading:8020884-...lld:pubmed
pubmed-article:8020884pubmed:meshHeadingpubmed-meshheading:8020884-...lld:pubmed
pubmed-article:8020884pubmed:meshHeadingpubmed-meshheading:8020884-...lld:pubmed
pubmed-article:8020884pubmed:meshHeadingpubmed-meshheading:8020884-...lld:pubmed
pubmed-article:8020884pubmed:meshHeadingpubmed-meshheading:8020884-...lld:pubmed
pubmed-article:8020884pubmed:meshHeadingpubmed-meshheading:8020884-...lld:pubmed
pubmed-article:8020884pubmed:meshHeadingpubmed-meshheading:8020884-...lld:pubmed
pubmed-article:8020884pubmed:meshHeadingpubmed-meshheading:8020884-...lld:pubmed
pubmed-article:8020884pubmed:meshHeadingpubmed-meshheading:8020884-...lld:pubmed
pubmed-article:8020884pubmed:meshHeadingpubmed-meshheading:8020884-...lld:pubmed
pubmed-article:8020884pubmed:meshHeadingpubmed-meshheading:8020884-...lld:pubmed
pubmed-article:8020884pubmed:meshHeadingpubmed-meshheading:8020884-...lld:pubmed
pubmed-article:8020884pubmed:year1994lld:pubmed
pubmed-article:8020884pubmed:articleTitleReduced expression of glutathione S-transferase Yb2 during progression of chemically induced hepatocellular carcinomas in Fischer 344 rats.lld:pubmed
pubmed-article:8020884pubmed:affiliationDepartment of Pathology, University of Guelph, Ontario, Canada.lld:pubmed
pubmed-article:8020884pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8020884pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed